• Pricing research and optimisation of P&R strategies.
• Value-based pricing methods.
• Preparation of reimbursement dossiers to meet country-specific and clinical context-specific requirements, including health economic and budget impact analyses.
• Assessment of product impact on the balance of power between various stakeholders.
• Support for integration of products into appropriate funding schemes.